The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation

<p>Abstract</p> <p>Background</p> <p>Activated microglia are a feature of the host response to neurodegeneration in Parkinson's disease (PD) and are thought to contribute to disease progression. Recent evidence suggests that extracellular α-synuclein (eSNCA) may pl...

Full description

Bibliographic Details
Main Authors: Couch Yvonne, Alvarez-Erviti Lydia, Sibson Nicola R, Wood Matthew JA, Anthony Daniel C
Format: Article
Language:English
Published: BMC 2011-11-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:http://www.jneuroinflammation.com/content/8/1/166
id doaj-aff0787fe2ea4b89a73591978d3890c7
record_format Article
spelling doaj-aff0787fe2ea4b89a73591978d3890c72020-11-25T00:47:56ZengBMCJournal of Neuroinflammation1742-20942011-11-018116610.1186/1742-2094-8-166The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammationCouch YvonneAlvarez-Erviti LydiaSibson Nicola RWood Matthew JAAnthony Daniel C<p>Abstract</p> <p>Background</p> <p>Activated microglia are a feature of the host response to neurodegeneration in Parkinson's disease (PD) and are thought to contribute to disease progression. Recent evidence suggests that extracellular α-synuclein (eSNCA) may play an important role in the pathogenesis of PD and that this may be mediated by a microglial response.</p> <p>Methods</p> <p>We wished to discover whether the host response to eSNCA would be sufficient to induce significant cytokine production. <it>In vitro </it>cultured BV-2 microglia were used to determine the basic inflammatory response to eSNCA. <it>In vivo</it>, 8-week old Biozzi mice were subjected to a single intranigral injection of either 3 μg SNCA, lipopolysaccharide (LPS) or serum protein (BSA) and allowed to recover for 24 hours. A second cohort of animals were peripherally challenged with LPS (0.5 mg/kg) 6 hours prior to tissue collection. Inflammation was studied by quantitative real-time PCR for a number of pro-inflammatory genes and immunohistochemistry for microglial activation, endothelial activation and cell death.</p> <p>Results</p> <p><it>In vitro </it>data showed a robust microglial response to SNCA, including a positive NFĸB response and the production of pro-inflammatory cytokines. Direct injection of SNCA into the substantia nigra resulted in the upregulation of mRNA expression of proinflammatory cytokines, the expression of endothelial markers of inflammation and microglial activation. However, these results were significantly different to those obtained after direct injection of LPS. By contrast, when the animals were injected intracerebrally with SNCA and subsequently challenged with systemic LPS, the level of production of IL-1β in the substantia nigra became comparable to that induced by the direct injection of LPS into the brain. The injection of albumin into the nigra with a peripheral LPS challenge did not provoke the production of a significant inflammatory response. Direct injection of LPS into the substantia nigra also induces cell death in a more robust manner than direct injection of either SNCA or BSA.</p> <p>Conclusion</p> <p>These results suggest that the presence of eSNCA protein 'primes' microglia, making them susceptible to environmental proinflammatory challenge. For this reason, we hypothesise that where 'inflammation' contributes to the disease progression in PD, it does so in a punctuate manner (on-off) as a result of systemic events.</p> http://www.jneuroinflammation.com/content/8/1/166braininflammationα-synucleinSNCAcytokineParkinson'schemokine
collection DOAJ
language English
format Article
sources DOAJ
author Couch Yvonne
Alvarez-Erviti Lydia
Sibson Nicola R
Wood Matthew JA
Anthony Daniel C
spellingShingle Couch Yvonne
Alvarez-Erviti Lydia
Sibson Nicola R
Wood Matthew JA
Anthony Daniel C
The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
Journal of Neuroinflammation
brain
inflammation
α-synuclein
SNCA
cytokine
Parkinson's
chemokine
author_facet Couch Yvonne
Alvarez-Erviti Lydia
Sibson Nicola R
Wood Matthew JA
Anthony Daniel C
author_sort Couch Yvonne
title The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
title_short The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
title_full The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
title_fullStr The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
title_full_unstemmed The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
title_sort acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
publisher BMC
series Journal of Neuroinflammation
issn 1742-2094
publishDate 2011-11-01
description <p>Abstract</p> <p>Background</p> <p>Activated microglia are a feature of the host response to neurodegeneration in Parkinson's disease (PD) and are thought to contribute to disease progression. Recent evidence suggests that extracellular α-synuclein (eSNCA) may play an important role in the pathogenesis of PD and that this may be mediated by a microglial response.</p> <p>Methods</p> <p>We wished to discover whether the host response to eSNCA would be sufficient to induce significant cytokine production. <it>In vitro </it>cultured BV-2 microglia were used to determine the basic inflammatory response to eSNCA. <it>In vivo</it>, 8-week old Biozzi mice were subjected to a single intranigral injection of either 3 μg SNCA, lipopolysaccharide (LPS) or serum protein (BSA) and allowed to recover for 24 hours. A second cohort of animals were peripherally challenged with LPS (0.5 mg/kg) 6 hours prior to tissue collection. Inflammation was studied by quantitative real-time PCR for a number of pro-inflammatory genes and immunohistochemistry for microglial activation, endothelial activation and cell death.</p> <p>Results</p> <p><it>In vitro </it>data showed a robust microglial response to SNCA, including a positive NFĸB response and the production of pro-inflammatory cytokines. Direct injection of SNCA into the substantia nigra resulted in the upregulation of mRNA expression of proinflammatory cytokines, the expression of endothelial markers of inflammation and microglial activation. However, these results were significantly different to those obtained after direct injection of LPS. By contrast, when the animals were injected intracerebrally with SNCA and subsequently challenged with systemic LPS, the level of production of IL-1β in the substantia nigra became comparable to that induced by the direct injection of LPS into the brain. The injection of albumin into the nigra with a peripheral LPS challenge did not provoke the production of a significant inflammatory response. Direct injection of LPS into the substantia nigra also induces cell death in a more robust manner than direct injection of either SNCA or BSA.</p> <p>Conclusion</p> <p>These results suggest that the presence of eSNCA protein 'primes' microglia, making them susceptible to environmental proinflammatory challenge. For this reason, we hypothesise that where 'inflammation' contributes to the disease progression in PD, it does so in a punctuate manner (on-off) as a result of systemic events.</p>
topic brain
inflammation
α-synuclein
SNCA
cytokine
Parkinson's
chemokine
url http://www.jneuroinflammation.com/content/8/1/166
work_keys_str_mv AT couchyvonne theacuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT alvarezervitilydia theacuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT sibsonnicolar theacuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT woodmatthewja theacuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT anthonydanielc theacuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT couchyvonne acuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT alvarezervitilydia acuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT sibsonnicolar acuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT woodmatthewja acuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT anthonydanielc acuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
_version_ 1725257778067406848